4 takeaways from MDUFA VI draft agreement

The FDA's MDUFA VI draft agreement outlines regulatory goals for medical device reviews covering 2028 to 2032, providing insight into future premarket approval timelines and agency priorities for device manufacturers. The agreement shapes the regulatory landscape for medical device clearance and approval processes.